RUTGERS Cancer Institute — New Brunswick, New Jersey

RUTGERS Cancer Institute is a clinical research site located in New Brunswick, New Jersey, United States 08901.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

RUTGERS Cancer Institute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer.

Sponsors: Iambic Therapeutics, Inc.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for RUTGERS Cancer Institute?

RUTGERS Cancer Institute has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has RUTGERS Cancer Institute conducted?

RUTGERS Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer.

Is RUTGERS Cancer Institute accredited by Crixeo Health?

RUTGERS Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about RUTGERS Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.